Almi Invest is a venture capital firm based in Sweden, established in 2009. It focuses on investing in Swedish startups with promising, scalable business models led by motivated entrepreneurs. Almi Invest operates seven regionally based funds, managing a total capital of SEK 1 billion. The firm typically makes initial investments ranging from SEK 2 million to SEK 4 million, with the potential to invest up to SEK 10 million over the lifetime of a venture. Almi Invest emphasizes a strong entrepreneurial team and an initial revenue stream over specific industry sectors, allowing for diverse investment opportunities across technology, fintech, life sciences, and sustainability sectors, among others. The firm partners with other investors, acquiring a maximum of 50 percent of shares in a new issuance, and reinvests generated yields, functioning as an Evergreen Fund. Half of its funding originates from European Union structural funds, complemented by regional investors and its founding organization, ALMI Företagspartner.
Nordic SeaFarm is a producer of fair-trade seaweed, focusing on organic seaweed cultivation that utilizes carbon dioxide and phosphorus for crop growth. The company collaborates with various stakeholders in the food chain to develop innovative products and services related to aquaculture. By promoting sustainable practices, Nordic SeaFarm provides customers with a reliable source of plant-based food, contributing to environmentally friendly solutions in the food industry.
EmbeDL is a software company that specializes in developing optimization engine software aimed at enhancing artificial intelligence and deep learning models. Originating as a spin-off from a collaborative research project focused on low energy computing, the company integrates proprietary algorithms with advancements from the research community. EmbeDL's software not only aims to maintain high levels of accuracy and precision but also assesses the most suitable hardware for specific models. This capability allows clients to achieve faster performance while conserving energy by minimizing processing power requirements.
Alertix Veterinary Diagnostics AB provides is a biotechnology company engages in development and research of in vitro assays, serums, and biomarkers for early detection and monitoring of cancer diseases in dogs, cats and horses. It offers Alertix Canine, an immunodiagnostic assay for measuring the presence of the enzyme thymidine kinase (TK1) in blood from dogs; Alertix immunodiagnostic assay for cat TK1; and Alertix immunodiagnostic assay for horse TK1. It also provides cancer detection and testing services. Alertix Veterinary Diagnostics AB was founded in 2017 and is headquartered in Kalmar, Sweden.
GESTRUMENT is the revolutionary gesture based instrument.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.